Scientific Investigations
Stability of Polysomnography for One Year and Longer in Children with Sickle Cell Disease
http://dx.doi.org/10.5664/jcsm.2150
Jonathan E. Mullin, M.D.1; Benjamin P. Cooper, M.P.H.2; Fenella J. Kirkham, M.D.3; Carol L. Rosen, M.D., F.A.A.S.M.4; Robert C. Strunk, M.D.5; Michael R. DeBaun, M.D.6; Susan Redline, M.D., M.P.H.7; James S. Kemp, M.D.5
1Case Western Reserve University School of Medicine, Cleveland, OH; 2St. Louis University School of Public Health, St. Louis, MO; 3UCL Institute of Child Health, London, UK; 4Department of Pediatrics, Division of Pediatric Pulmonology, Case Western Reserve University School of Medicine, Cleveland, OH; 5Department of Pediatrics, Washington University School of Medicine, St. Louis, MO; 6Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN; 7Department of Medicine, Harvard Medical School, Brigham and Women's Hospital and Beth Israel Deaconess Medical Center, Boston, MA
Study Objectives:
Serious morbidity may be linked to sleep disordered breathing (SDB) among children with sickle cell disease (SCD). We investigated the stability of polysomnography (PSG) results among children not having acute complications of SCD.
Methods:
Two PSGs were performed on a subsample of 63 children 4 to 18 years of age from the Sleep and Asthma Cohort Study. All had Hb SS or HbSβ0 disease. Two PSGs were compared for 45 subjects. Excluded from comparison were 18 children who had begun transfusions or hydroxyurea, had an adenotonsillectomy between the PSGs, or had a pain crisis or the acute chest syndrome within 3 months of the second PSG. Sleep disordered breathing was identified using 2 thresholds for the apnea hypopnea index (AHI): ≥ 2 or ≥ 5 respiratory events per hour.
Results:
Ages were 12.3 yrs ± 4.0, BMI, 18.2 ± 3.2. Interval between PSGs was 581 ± 119 days (19.1 ± 3.9 months). Ten of 45 changed from ≥ 2 events per hour to < 2; 3 of 45 from < 2 to ≥ 2; 7 of 45 had ≥ 2 on both nights. Six of 45 changed from ≥ 5 to < 5, 2 of 45 from < 5 to ≥ 5, and 1 had ≥ 5 on both nights (McNemar χ2, p = 0.09, and p = 0.29).
Conclusions:
In the absence of acute SCD complications, overnight PSG usually remains stable or improves over a 12- to 30-month period. Only 6.7% subjects, or fewer, had AHI on a subsequent PSG that would re-classify the child as having SDB not identified in the earlier PSG.
Citation:
Mullin JE; Cooper BP; Kirkham FJ; Rosen CL; Strunk RC; DeBaun MR; Redline S; Kemp JS. Stability of polysomnography for one year and longer in children with sickle cell disease. J Clin Sleep Med 2012;8(5):535-539.
Please login to continue reading the full article
Subscribers to JCSM get full access to current and past issues of the JCSM.
Login to JCSM
Not a subscriber?
Join the American Academy of Sleep Medicine and receive a subscription to JCSM with your membership